Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 
First Western Ship Transits Strait of Hormuz Since Iran War Began 
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage 
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
Britain Courts Anthropic Amid US Defense Department Dispute 
Apple Turns 50: From Garage Startup to AI Crossroads 
LOUISVILLE, Ky., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that the state of Vermont has adopted Appriss' Prescription Drug Monitoring Solution to improve patient safety and help deter prescription drug abuse and drug diversion.
Prescription Monitoring Programs (PMPs) are state-run programs that track the distribution of narcotics and other prescriptions for federally controlled substances. Appriss's PMP platform provides access to mandatory pharmacy reporting and offers secure accessibility to data across state lines.
"Appriss is committed to ensuring patient safety," says Krishnan Sastry, Executive Vice President of Appriss, Inc. "Appriss's solution will support providers and dispensers in Vermont to ensure better prescribing decisions and help state administrators analyze patterns of consumption to drive patient safety and health policy."
Vermont implemented the PMP platform in October and joins 23 other states in choosing Appriss' PMP Solution to address prescription drug abuse and diversion.
About Appriss
Appriss provides data-driven solutions to fulfill our mission of keeping communities safe and informed. Partnering with public safety, healthcare, and leading private and public companies, Appriss delivers solutions that prevent fraud, mitigate risk, fight crime, ensure compliance, increase public safety and save lives. Appriss' solutions are always backed by excellent customer support with technical agents in the US that are available to help 24x7x365.
For more information, visit www.appriss.com (http://www.appriss.com).
CONTACT: Kathy Sue Bennett
Marketing Manager
[email protected]
